Liver magnetic resonance diffusion weighted imaging: 2011 update

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 8-9, 2011, Pages 539-548

  Chiaradia, Mélanie ^a,b   Baranes, Laurence ^a,b   Pigneur, Frederic ^a   Djabbari, Marjan ^a   Zegai, Benhalima ^a   Brugières, Pierre ^a,b   Zerbib, Pierre ^a   Decaens, Thomas ^a,b   Deux, Jean François ^a,b   Kobeiter, Hicham ^a,b   Rahmouni, Alain ^a,b   Luciani, Alain ^a,b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c INSERM U955   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; HEPATOGRAPHY; HUMAN; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER CYST; LIVER FIBROSIS; LIVER HEMANGIOMA; LIVER METASTASIS; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; TUMOR DIFFERENTIATION;

DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LIVER DISEASES;

EID: 80052543682     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.05.001     Document Type: Short Survey

References (55)

1. Stejskal E.O., Tanner J.E. Spin diffusion measurement: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965, 42(1):288-292.
2. Lin C, Itti E, Luciani A et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study. Invest Radiol 2011;46:341-49.
3. Lin C et al. Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 2010;20(8):2027-38.
4. Tanner J.E., Stejskal E.O. Restricted self-diffusion of protons in colloidal systems by the pulsed-gradient, spin-echo method. J Chem Phys 1968, 49(4):1768-1777.
5. Vilgrain V., et al. Diffusion-weighted MR imaging of the liver. J Radiol 2010, 91(3 Pt 2):381-390. [quiz 391-3].
6. Taouli B., Koh D.M. Diffusion-weighted MR imaging of the liver. Radiology 2010, 254(1):47-66.
7. Luciani A., et al. Liver cirrhosis: intravoxel incoherent motion MR imaging - pilot study. Radiology 2008, 249(3):891-899.
8. Annet L., et al. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 2007, 25(1):122-128.
9. Doran M., Bydder G.M. Magnetic resonance: perfusion and diffusion imaging. Neuroradiology 1990, 32(5):392-398.
10. Callot V., et al. In vivo study of microcirculation in canine myocardium using the IVIM method. Magn Reson Med 2003, 50(3):531-540.
11. Le Bihan D., Turner R., MacFall J.R. Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: application to molecular diffusion imaging. Magn Reson Med 1989, 10(3):324-337.
12. Le Bihan D., et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988, 168(2):497-505.
13. Yamada I., et al. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999, 210(3):617-623.
14. Taouli B., et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003, 226(1):71-78.
15. Ichikawa T., et al. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998, 170(2):397-402.
16. Padhani A.R., et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009, 11(2):102-125.
17. Braithwaite A.C., et al. Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology 2009, 250(2):459-465.
18. Lu T.L., et al. Interobserver and intraobserver variability of the apparent diffusion coefficient in treated malignant hepatic lesions on a 3.0T machine: measurements in the whole lesion versus in the area with the most restricted diffusion. J Magn Reson Imaging 2010, 32(3):647-653.
19. Dale B.M., et al. Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen. Invest Radiol 2010, 45(2):104-108.
20. Rosenkrantz A.B., et al. Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging 2011, 33(1):128-135.
21. Turner R., Le Bihan D., Chesnick A.S. Echo-planar imaging of diffusion and perfusion. Magn Reson Med 1991, 19(2):247-253.
22. Taouli B., et al. Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers. AJR Am J Roentgenol 2004, 183(3):677-680.
23. Taouli B., et al. Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging 2009, 30(3):561-568.
24. Nasu K., Kuroki Y., Sekiguchi R., et al. The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci 2006, 5:129-136.
25. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24(2):289-293.
26. Lewin M., et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007, 46(3):658-665.
27. Taouli B., et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 2007, 189(4):799-806.
28. Do R.K., et al. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol 2010, 195(3):671-676.
29. Patel J., et al. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 2010, 31(3):589-600.
30. Parikh T., et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008, 246(3):812-822.
31. Coenegrachts K., et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 2007, 80(955):524-531.
32. Coenegrachts K., et al. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI. J Magn Reson Imaging 2008, 27(1):117-124.
33. Bruegel M., et al. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol 2008, 191(5):1421-1429.
34. Zech C.J., et al. Black-blood diffusion-weighted EPI acquisition of the liver with parallel imaging: comparison with a standard T2-weighted sequence for detection of focal liver lesions. Invest Radiol 2008, 43(4):261-266.
35. Nasu K, Kuroki Y, Nawano S et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology. 2006;239:122-130.
36. Soyer P., et al. Differentiation between true focal liver lesions and pseudolesions in patients with fatty liver: evaluation of helical CT criteria. Eur Radiol 2010, 20(7):1726-1737.
37. Shimada K., et al. Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 2010, 20(11):2690-2698.
38. Koh D.M., et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol 2008, 18(5):903-910.
39. Coenegrachts K., et al. Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases. Eur Radiol 2009, 19(2):370-379.
40. Xu P.J., et al. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. J Comput Assist Tomogr 2010, 34(4):506-512.
41. Zech C.J., Reiser M.F., Herrmann K.A. Imaging of hepatocellular carcinoma by computed tomography and magnetic resonance imaging: state of the art. Dig Dis 2009, 27(2):114-124.
42. Vandecaveye V., et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol 2009, 19(10):2456-2466.
43. Piana G, et al. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Hepatol 2010.
44. Miller F.H., et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 2010, 32(1):138-147.
45. Sandrasegaran K., et al. The value of diffusion-weighted imaging in characterizing focal liver masses. Acad Radiol 2009, 16(10):1208-1214.
46. Nasu K., et al. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol 2009, 193(2):438-444.
47. Thoeny H.C., et al. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 2005, 237(2):492-499.
48. Marugami N., et al. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging. Cardiovasc Intervent Radiol 2009, 32(4):638-646.
49. Vossen J.A., et al. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. J Comput Assist Tomogr 2008, 32(3):347-352.
50. Cui Y., et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008, 248(3):894-900.
51. Koh D.M., et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007, 188(4):1001-1008.
52. Kamel I.R., et al. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol 2003, 181(3):708-710.
53. Chen C.Y., et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience. Radiology 2006, 239(2):448-456.
54. Chung J.C., et al. Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World J Gastroenterol 2010, 16(25):3161-3167.
55. Bruegel M., et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008, 18(3):477-485.